Sort   by:  
 Page size 
UnknownTherapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
Not available
S-EPMC4631316 | biostudies-literature
UnknownThe Variation in Practice of the Living Donor Kidney Transplant Pathway in the UK: Results of a National Survey.
Not available
S-EPMC12650412 | biostudies-literature
UnknownAbiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Not available
S-EPMC8811484 | biostudies-literature
UnknownEffect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Not available
S-EPMC7042887 | biostudies-literature
UnknownEffect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Not available
S-EPMC6143100 | biostudies-literature
UnknownCalculation of ATP production rates using the Seahorse XF Analyzer
Not available
S-SCDT-10_15252-EMBR_202256380 | biostudies-other
UnknownThe Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction.
Not available
S-EPMC11096866 | biostudies-literature
UnknownAbiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Not available
S-EPMC7616864 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownAddition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Not available
S-EPMC4800035 | biostudies-literature
Sort   by:  
 Page size